We were delighted to meet up with Noel Alpins (NewVision Clinic, Victoria, Australia) again to hear about the PROWL-1 and PROWL-2 studies, and reports the patients most likely to benefit from LASIK vector planning.
1. What were the aims of the PROWL-1 and PROWL-2 studies? (0:04)
2. What were the incidences of glare, starburst and halos in these studies? (2:00)
3. What are the causes of glare and halos? (3:34)
4. How can we reduce the incidence of glare and halos after LASIK? (4:40)
5. Which patients are likely to benefit most from LASIK vector planning and in whom is it contraindicated? (6:06)
Support: No funding was received in the production of this video.
Share this Video
Related Videos In Refractive Surgery
Noel Alpins, ESCRS 2020 – Treatment of Astigmatism Using Vector Planning Paradigm
It was a pleasure to catch up with Prof. Noel Alpins (Department of Ophthalmology, Melbourne University, Melbourne, Australia), as he discussed the major challenges of refractive surgery in the treatment of astigmatism, and the evidence for the use of Vector Planning in clinical practice. Questions What are the major challenges of refractive surgery in the […]
Iben Bach Damgaard, ESCRS 2020 – Intrastromal Lenticule Rotation for Mixed Astigmatism
Prof. Iben Bach Damgaard (Aarhus University Hospital, Aarhus, Denmark) kindly spoke to us about her ESCRS presentation on intrastromal lenticule rotation for mixed astigmatism. Questions What are the limitations of current approaches in the treatment of mixed astigmatism? (00:08) Could you give us a brief overview of intrastromal lenticule rotation? (00:44) What are the challenges […]
Cornelis Verdoorn, ESCRS 2020 – Corneal Inlay
We spoke with Cornelis Verdoorn (Lasik Centrum Eye Clinic, Boxtel, the Netherlands) about his presentation at ESCRS 2020, on corneal inlays for the treatment of presbyopia. Questions Could you give us an overview of the use of corneal inlays to treat presbyopia? (00:39) Why has there not yet been widespread market adoption of corneal inlays? […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!